Get started
Author

Joseph Lutaakome

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
2022 · Thomas L. Holland, Adit A. Ginde, et al. · The Lancet Respiratory Medicine · 123
PDF
A Randomized Trial of Prolonged Co-trimoxazole in HIV-Infected Children in Africa
2014 · Mutsawashe Bwakura-Dangarembizi, Lindsay Kendall, et al. · New England Journal of Medicine · 115
Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation
2019 · Claire D. Bourke, Ethan K. Gough, et al. · Science Translational Medicine · 104
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60
PDF
Cardiometabolic risk among hiv-positive Ugandan adults: prevalence, predictors and effect of long-term antiretroviral therapy
2017 · Patrick Kazooba, Ivan Kasamba, et al. · Pan African Medical Journal · 49
PDF
Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy
2011 · Andrew Prendergast, Mutsa F Bwakura-Dangarembizi, et al. · AIDS · 48
Prevalence and factors associated with hypertension among people living with HIV/AIDS on antiretroviral therapy in Uganda
2021 · Gloria Lubega, Billy Mayanja, et al. · Pan African Medical Journal · 45
PDF
Pediatric Underdosing of Efavirenz
2011 · Quirine Fillekes, Eva Natukunda, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 38
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31
PDF
Bacteremia, Causative Agents and Antimicrobial Susceptibility Among HIV-1–infected Children on Antiretroviral Therapy in Uganda and Zimbabwe
2013 · Victor Musiime, Adrian Cook, et al. · The Pediatric Infectious Disease Journal · 27
Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial
2018 · Zacchaeus Anywaine, Jonathan Levin, et al. · PLoS ONE · 22
PDF
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15
PDF
From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults
2016 · On behalf of the CoLTART study team, Ivan Namakoola, et al. · BMC Research Notes · 12
PDF
Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size
2022 · Thomas A Rasmussen, Sunil K Ahuja, et al. · Clinical Infectious Diseases · 11
PDF
Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
2016 · Andrew J. Prendergast, Mutsa Bwakura-Dangarembizi, et al. · AIDS · 6
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19
2023 · Tomas O Jensen, Greg A Grandits, et al. · The Journal of Infectious Diseases · 4
PDF
The bacterial profile and antibiotic susceptibility pattern in respiratory tract samples from art-experienced HIV-positive adults in Uganda
2023 · Gloria Lubega, Andrew Abaasa, et al. · PLoS ONE · 3
PDF
Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV
2023 · David M. MacDonald, Sarah Samorodnitsky, et al. · Scientific Reports · 3
PDF
Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)
2022 · Eleftherios Mylonakis, Joseph Lutaakome, et al. · Med · 3
PDF
Tixagevimab/Cilgavimab for Treatment of Hospitalised COVID-19 Patients: A Randomised, Double-Blind, Phase 3 Trial
2022 · Thomas L. Holland, Adit A. Ginde, et al. · SSRN Electronic Journal · 3
Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials
2025 · Kirk U. Knowlton, Lianne K. Siegel, et al. · PLoS Medicine · 2
PDF
Pharmacokinetics, Safety and Antiviral Activity of Rilpivirine in Antiretroviral-naïve Children With HIV ≥6 to <12 Years Old: Week 48 and Final Analysis of Cohort 2 From the Open-label, Phase 2 PAINT Study
2025 · Johan Lombaard, Visal Moolasart, et al. · The Pediatric Infectious Disease Journal · 2
Vitamin B12 deficiency presenting as progressive blindness in a 33-year-old HIV-positive female patient on Efavirenz-based regimen: case report
2024 · Gloria Lubega, Joseph Lutaakome, et al. · Pan African Medical Journal · 2
Acute kwashiorkor soon after initiating ART among HIV infected children in the ARROW (AntiRetroviral Research fOr Watoto) trial.
2009 · Mutsa Bwakura‐Dangarembizi, Adrian Cook, et al. · 1
Knowledge, perceptions, uptake, and determinants of HPV vaccination, and preferred delivery strategies among out-of-school girls in Masaka, Uganda
2026 · Jonathan Kitonsa, Paddy Kafeero, et al. · Human Vaccines & Immunotherapeutics
PDF
Works count: 35
Citation count: 808
H-index: 14
I10-index: 16
Year
Topic
Type